| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.5 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.03 | 0.5 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.5 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |